by Elleine Allapitan | Jul 4, 2023
MIGALASTAT SWITCH Summary: Evaluation of Biomarkers for patients receiving migalastat after switching from...
by Elleine Allapitan | May 25, 2023
FABRY HCM Summary: Screening for Fabry cardiomyopathy using cardiac magnetic resonance...
by Elleine Allapitan | Feb 8, 2023
PERIDOT PAtient ExpeRIence in Fabry Disease On VenglustaT Summary: A randomized, double-blind, placebo-controlled, 12-month Phase III study to evaluate the effect of Venglustat on neuropathic and abdominal pain in male and female adults with Fabry disease who are...
Recent Comments